Do analysts prefer APYX or BDMD?

Apyx Medical currently has a consensus price target of $6.50, indicating a potential upside of 150.97%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Apyx Medical is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 1 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.75 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, APYX or BDMD?

Baird Medical Investment has lower revenue, but higher earnings than Apyx Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apyx Medical $52.84M 2.06 -$11.21M -$0.20 N/A Baird Medical Investment $22.54M 1.44 N/A N/A N/A

Do analysts recommend BDMD or CNXU?

Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 414.14%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Conexeu Sciences is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Conexeu Sciences 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, BDMD or CNXU?

Baird Medical Investment has higher revenue and earnings than Conexeu Sciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 1.44 N/A N/A N/A Conexeu Sciences N/A N/A -$3.92M -$0.40 N/A

Is BDMD or CNXU more profitable?

Baird Medical Investment's return on equity of 0.00% beat Conexeu Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A Conexeu Sciences N/A -200.20% -177.26%

Does the media favor BDMD or CNXU?

In the previous week, Conexeu Sciences had 2 more articles in the media than Baird Medical Investment. MarketBeat recorded 5 mentions for Conexeu Sciences and 3 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.82 beat Conexeu Sciences' score of 0.48 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Conexeu Sciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer KEQU or BDMD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, KEQU or BDMD?

Kewaunee Scientific has higher revenue and earnings than Baird Medical Investment. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Kewaunee Scientific $282M 0.35 $9.62M $2.76 12.24 Baird Medical Investment $22.54M 1.44 N/A N/A N/A

Does the media refer more to KEQU or BDMD?

In the previous week, Baird Medical Investment had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for Baird Medical Investment and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.28 beat Baird Medical Investment's score of 0.82 indicating that Kewaunee Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kewaunee Scientific 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate BDMD or HYPR?

Hyperfine has a consensus price target of $2.03, indicating a potential upside of 118.47%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hyperfine 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40

Which has stronger valuation and earnings, BDMD or HYPR?

Baird Medical Investment has higher revenue and earnings than Hyperfine. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 1.44 N/A N/A N/A Hyperfine $11.40M 8.66 -$35.57M -$0.38 N/A

Does the media prefer BDMD or HYPR?

In the previous week, Hyperfine had 6 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Hyperfine and 3 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.82 beat Hyperfine's score of 0.61 indicating that Baird Medical Investment is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hyperfine 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer BDMD or ECOR?

electroCore has a consensus price target of $18.00, suggesting a potential upside of 86.34%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Baird Medical Investment. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baird Medical Investment 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 electroCore 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable valuation & earnings, BDMD or ECOR?

Baird Medical Investment has higher earnings, but lower revenue than electroCore. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Baird Medical Investment $22.54M 1.44 N/A N/A N/A electroCore $32.03M 2.72 -$13.97M -$1.66 N/A

Is BDMD or ECOR more profitable?

Baird Medical Investment has a net margin of 0.00% compared to electroCore's net margin of -39.96%. Company Net Margins Return on Equity Return on Assets Baird Medical Investment N/A N/A N/A electroCore -39.96% N/A -81.35%

Does the media prefer BDMD or ECOR?

In the previous week, Baird Medical Investment had 1 more articles in the media than electroCore. MarketBeat recorded 3 mentions for Baird Medical Investment and 2 mentions for electroCore. electroCore's average media sentiment score of 0.89 beat Baird Medical Investment's score of 0.82 indicating that electroCore is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baird Medical Investment 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive electroCore 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Baird Medical Investment (BDMD) Competitors

$0.77 -0.02 (-2.53%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$0.77 +0.00 (+0.39%)

As of 10/9/2026 05:53 PM Eastern

Compare

BDMD vs. APYX, CNXU, KEQU, HYPR, and ECOR

Should you buy Baird Medical Investment stock or one of its competitors? Baird Medical Investment's main competitors and comparable companies include Apyx Medical (APYX), Conexeu Sciences (CNXU), Kewaunee Scientific (KEQU), Hyperfine (HYPR), and electroCore (ECOR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Baird Medical Investment compare to Apyx Medical?

Apyx Medical (NASDAQ:APYX) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 15.9% of Apyx Medical shares are held by insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Apyx Medical currently has a consensus price target of $6.50, indicating a potential upside of 150.97%. Given Apyx Medical's stronger consensus rating and higher possible upside, equities research analysts plainly believe Apyx Medical is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Apyx Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Baird Medical Investment has lower revenue, but higher earnings than Apyx Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apyx Medical	$52.84M	2.06	-$11.21M	-$0.20	N/A
Baird Medical Investment	$22.54M	1.44	N/A	N/A	N/A

Apyx Medical has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.11, meaning that its stock price is 211% less volatile than the broader market.

In the previous week, Baird Medical Investment had 2 more articles in the media than Apyx Medical. MarketBeat recorded 3 mentions for Baird Medical Investment and 1 mentions for Apyx Medical. Apyx Medical's average media sentiment score of 1.79 beat Baird Medical Investment's score of 0.82 indicating that Apyx Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Apyx Medical	Very Positive
Baird Medical Investment	Positive

Baird Medical Investment has a net margin of 0.00% compared to Apyx Medical's net margin of -14.78%. Baird Medical Investment's return on equity of 0.00% beat Apyx Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Apyx Medical	-14.78%	-76.60%	-13.91%
Baird Medical Investment	N/A	N/A	N/A

Summary

Apyx Medical beats Baird Medical Investment on 9 of the 14 factors compared between the two stocks.

How does Baird Medical Investment compare to Conexeu Sciences?

Baird Medical Investment (NASDAQ:BDMD) and Conexeu Sciences (NASDAQ:CNXU) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

Conexeu Sciences has a consensus price target of $20.00, indicating a potential upside of 414.14%. Given Conexeu Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Conexeu Sciences is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Conexeu Sciences	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Conexeu Sciences had 2 more articles in the media than Baird Medical Investment. MarketBeat recorded 5 mentions for Conexeu Sciences and 3 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.82 beat Conexeu Sciences' score of 0.48 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Conexeu Sciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Baird Medical Investment's return on equity of 0.00% beat Conexeu Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Conexeu Sciences	N/A	-200.20%	-177.26%

19.8% of Baird Medical Investment shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Baird Medical Investment has higher revenue and earnings than Conexeu Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	1.44	N/A	N/A	N/A
Conexeu Sciences	N/A	N/A	-$3.92M	-$0.40	N/A

Summary

Baird Medical Investment beats Conexeu Sciences on 6 of the 10 factors compared between the two stocks.

How does Baird Medical Investment compare to Kewaunee Scientific?

Kewaunee Scientific (NASDAQ:KEQU) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Kewaunee Scientific has higher revenue and earnings than Baird Medical Investment.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$282M	0.35	$9.62M	$2.76	12.24
Baird Medical Investment	$22.54M	1.44	N/A	N/A	N/A

Kewaunee Scientific has a net margin of 2.97% compared to Baird Medical Investment's net margin of 0.00%. Kewaunee Scientific's return on equity of 11.61% beat Baird Medical Investment's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	2.97%	11.61%	4.82%
Baird Medical Investment	N/A	N/A	N/A

Kewaunee Scientific has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.11, meaning that its stock price is 211% less volatile than the broader market.

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by insiders. Comparatively, 78.9% of Baird Medical Investment shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Baird Medical Investment had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 3 mentions for Baird Medical Investment and 2 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 1.28 beat Baird Medical Investment's score of 0.82 indicating that Kewaunee Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kewaunee Scientific	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Kewaunee Scientific beats Baird Medical Investment on 8 of the 11 factors compared between the two stocks.

How does Baird Medical Investment compare to Hyperfine?

Baird Medical Investment (NASDAQ:BDMD) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

In the previous week, Hyperfine had 6 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for Hyperfine and 3 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 0.82 beat Hyperfine's score of 0.61 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hyperfine	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baird Medical Investment has higher revenue and earnings than Hyperfine.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	1.44	N/A	N/A	N/A
Hyperfine	$11.40M	8.66	-$35.57M	-$0.38	N/A

Hyperfine has a consensus price target of $2.03, indicating a potential upside of 118.47%. Given Hyperfine's stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hyperfine	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 26.3% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Baird Medical Investment has a net margin of 0.00% compared to Hyperfine's net margin of -210.75%. Baird Medical Investment's return on equity of 0.00% beat Hyperfine's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
Hyperfine	-210.75%	-97.88%	-61.81%

Baird Medical Investment has a beta of -1.11, indicating that its stock price is 211% less volatile than the broader market. Comparatively, Hyperfine has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

Summary

Baird Medical Investment beats Hyperfine on 7 of the 13 factors compared between the two stocks.

How does Baird Medical Investment compare to electroCore?

Baird Medical Investment (NASDAQ:BDMD) and electroCore (NASDAQ:ECOR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings.

electroCore has a consensus price target of $18.00, suggesting a potential upside of 86.34%. Given electroCore's stronger consensus rating and higher possible upside, analysts clearly believe electroCore is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Baird Medical Investment has a beta of -1.11, indicating that its share price is 211% less volatile than the broader market. Comparatively, electroCore has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to electroCore's net margin of -39.96%.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
electroCore	-39.96%	N/A	-81.35%

Baird Medical Investment has higher earnings, but lower revenue than electroCore.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	1.44	N/A	N/A	N/A
electroCore	$32.03M	2.72	-$13.97M	-$1.66	N/A

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 26.7% of electroCore shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 7.8% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Baird Medical Investment had 1 more articles in the media than electroCore. MarketBeat recorded 3 mentions for Baird Medical Investment and 2 mentions for electroCore. electroCore's average media sentiment score of 0.89 beat Baird Medical Investment's score of 0.82 indicating that electroCore is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baird Medical Investment	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
electroCore	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

electroCore beats Baird Medical Investment on 8 of the 12 factors compared between the two stocks.

Get Baird Medical Investment News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BDMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BDMD vs. The Competition

Export

Metric	Baird Medical Investment	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$32.50M	$5.49B	$7.25B	$13.30B
Dividend Yield	N/A	1.76%	2.52%	22.58%
P/E Ratio	N/A	25.57	275.29	26.14
Price / Sales	1.44	42.88	576.85	85.23
Price / Cash	N/A	32.11	76.96	53.71
Price / Book	N/A	5.95	11.22	6.33
Net Income	N/A	$146.18M	$3.50B	$382.15M
7 Day Performance	2.52%	-0.28%	-0.89%	-1.40%
1 Month Performance	-30.00%	-2.08%	-4.02%	-3.35%
1 Year Performance	-51.27%	5.39%	7.13%	1.49%

Baird Medical Investment Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BDMD Baird Medical Investment	1.2793 of 5 stars	$0.77 -2.5%	N/A	-51.3%	$32.50M	$22.54M	N/A	146	News Coverage Analyst Downgrade Gap Down
APYX Apyx Medical	3.6083 of 5 stars	$2.55 flat	$6.50 +154.9%	-12.8%	$107.41M	$52.84M	N/A	205	Positive News
CNXU Conexeu Sciences	2.0256 of 5 stars	$3.64 -0.5%	$20.00 +449.5%	N/A	$102.68M	N/A	N/A	4
KEQU Kewaunee Scientific	1.5718 of 5 stars	$33.84 +0.4%	N/A	-18.6%	$98.14M	$282M	12.26	1,231
HYPR Hyperfine	3.0498 of 5 stars	$0.85 -2.4%	$2.03 +139.5%	-46.8%	$90.04M	$16.54M	N/A	102	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BDMD) was last updated on 10/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baird Medical Investment (BDMD) Competitors

BDMD vs. APYX, CNXU, KEQU, HYPR, and ECOR

How does Baird Medical Investment compare to Apyx Medical?

Summary

How does Baird Medical Investment compare to Conexeu Sciences?

Summary

How does Baird Medical Investment compare to Kewaunee Scientific?

Summary

How does Baird Medical Investment compare to Hyperfine?

Summary

How does Baird Medical Investment compare to electroCore?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baird Medical Investment (BDMD) Competitors

BDMD vs. APYX, CNXU, KEQU, HYPR, and ECOR

How does Baird Medical Investment compare to Apyx Medical?

Do insiders and institutionals hold more shares of APYX or BDMD?

Do analysts prefer APYX or BDMD?

Which has preferable valuation & earnings, APYX or BDMD?

Which has more volatility & risk, APYX or BDMD?

Does the media favor APYX or BDMD?

Is APYX or BDMD more profitable?

Summary

How does Baird Medical Investment compare to Conexeu Sciences?

Do analysts recommend BDMD or CNXU?

Does the media favor BDMD or CNXU?

Is BDMD or CNXU more profitable?

Do insiders & institutionals believe in BDMD or CNXU?

Which has better earnings & valuation, BDMD or CNXU?

Summary

How does Baird Medical Investment compare to Kewaunee Scientific?

Do analysts prefer KEQU or BDMD?

Which has higher earnings & valuation, KEQU or BDMD?

Is KEQU or BDMD more profitable?

Which has more risk & volatility, KEQU or BDMD?

Do institutionals and insiders believe in KEQU or BDMD?

Does the media refer more to KEQU or BDMD?

Summary

How does Baird Medical Investment compare to Hyperfine?

Does the media prefer BDMD or HYPR?

Which has stronger valuation and earnings, BDMD or HYPR?

Do analysts rate BDMD or HYPR?

Do institutionals & insiders believe in BDMD or HYPR?

Is BDMD or HYPR more profitable?

Which has more risk & volatility, BDMD or HYPR?

Summary

How does Baird Medical Investment compare to electroCore?

Do analysts prefer BDMD or ECOR?

Which has more risk & volatility, BDMD or ECOR?

Is BDMD or ECOR more profitable?

Which has preferable valuation & earnings, BDMD or ECOR?

Do insiders & institutionals hold more shares of BDMD or ECOR?

Does the media prefer BDMD or ECOR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BDMD vs. The Competition

Baird Medical Investment Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools